Biotech Values

[DewDiligence]

AKUS IPOs 14.4M* shares @$17.00:

https://www.globenewswire.com/news-release/2020/06/25/2053797/0/en/Akouos-Announces-Pricing-of-Initial-Public-Offering.html

Akouos is a precision genetic medicine company dedicated to developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for people worldwide who live with disabling hearing loss.

…Headquartered in Boston, Akouos was founded in 2016 by leaders in the fields of neurotology, genetics, inner ear drug delivery and AAV gene therapy.

I’m not sure how the corporate name is pronounced.

*Assuming exercise of underwriter’s option.